Symposium - Emerging Clinical Issues in the Treatment of Women with Substance Use Disorders: from Pregnancy to Parenting
Jones, H., Burns, L., Gordon, A., Kaltenbach, K., Dunlop, A., Conroy, E., ... Perry, N. (2011). Symposium - Emerging Clinical Issues in the Treatment of Women with Substance Use Disorders: from Pregnancy to Parenting. In , pp. 45–46. .
Aims: This symposium will provide the audience with the latest emerging data and clinical implications of these data regarding the treatment of women for substance use disorders from the life milestones of pregnancy and continuing into parenting. The first presentation will provide a thought-provoking presentation of key health care and treatment issues facing pregnant women struggling with substance use disorders. Second, the latest synthesis and treatment implications from a comprehensive literature review regarding the management of benzodiazepine use disorders during pregnancy will be provided. Third, the most current data regarding the use of fl exible dosing from a multi-site, double-blind, randomised clinical trial comparing the safety and effi cacy of methadone and buprenorphine treatment for opioid-dependent patients during
pregnancy will be presented. These data will provide important guidance for medication changes for both methadone and buprenorphine with advancing gestation. Fourth, results from a parenting risk assessment will provide practical guidance for helping clinicians to assist their patients in improving their parenting skills. Finally, the symposium will conclude with an interactive panel discussion with the audience.